Published in J Agric Food Chem on June 09, 2010
Validated LC-MS/MS method for the determination of maackiain and its sulfate and glucuronide in blood: application to pharmacokinetic and disposition studies. J Pharm Biomed Anal (2011) 0.89
Permeability of rosmarinic acid in Prunella vulgaris and ursolic acid in Salvia officinalis extracts across Caco-2 cell monolayers. J Ethnopharmacol (2011) 0.82
An approach to optimize the batch mixing process for improving the quality consistency of the products made from traditional Chinese medicines. J Zhejiang Univ Sci B (2013) 0.75
Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun (1991) 3.25
Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center. J Gen Intern Med (2008) 2.08
St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties. J Pharm Pharmacol (2001) 1.75
Flavonoids from Hypericum perforatum show antidepressant activity in the forced swimming test. Planta Med (2000) 1.58
Metabolism of flavonoids via enteric recycling: mechanistic studies of disposition of apigenin in the Caco-2 cell culture model. J Pharmacol Exp Ther (2003) 1.32
Intestinal bacterial metabolism of flavonoids and its relation to some biological activities. Arch Pharm Res (1998) 1.20
Pharmacokinetic interactions of drugs with St John's wort. J Psychopharmacol (2004) 1.15
St. John's wort and depression: efficacy, safety and tolerability-an update. Life Sci (2002) 1.15
Cellular uptake of dietary flavonoid quercetin 4'-beta-glucoside by sodium-dependent glucose transporter SGLT1. J Pharmacol Exp Ther (2000) 1.14
Development and evaluation of an in vitro method for prediction of human drug absorption II. Demonstration of the method suitability. Eur J Pharm Sci (2005) 1.01
Efflux of dietary flavonoid quercetin 4'-beta-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein-2. J Pharmacol Exp Ther (2000) 1.01
Analysis of the hypericin and pseudohypericin content of commercially available St John's Wort preparations. Can J Clin Pharmacol (2003) 0.99
Quercetin-3-glucoside is transported by the glucose carrier SGLT1 across the brush border membrane of rat small intestine. J Nutr (2002) 0.98
Depression and suicide in children and adolescents. Pediatr Rev (2009) 0.91
Prediction of intestinal absorption and metabolism of pharmacologically active flavones and flavanones. Bioorg Med Chem (2008) 0.90
Complementary and alternative medicine in the treatment of bipolar disorder--a review of the evidence. J Affect Disord (2008) 0.89
Combining PARAFAC analysis of HPLC-PDA profiles and structural characterization using HPLC-PDA-SPE-NMR-MS experiments: commercial preparations of St. John's Wort. Anal Chem (2008) 0.87
Scavenging effects on active oxygen radicals by schizandrins with different structures and configurations. Free Radic Biol Med (1990) 0.86
Antioxidant and free radical scavenging properties of N-acetylcysteine amide (NACA) and comparison with N-acetylcysteine (NAC). Free Radic Res (2008) 0.85
Instability of St. John's wort (Hypericum perforatum L.) and degradation of hyperforin in aqueous solutions and functional beverage. J Agric Food Chem (2004) 0.85
Drug treatment of depression in the 1990s. An overview of achievements and future possibilities. Drugs (1996) 0.84
Intestinal absorption of hawthorn flavonoids--in vitro, in situ and in vivo correlations. Life Sci (2006) 0.84
The efflux of flavonoids morin, isorhamnetin-3-O-rutinoside and diosmetin-7-O-beta-D-xylopyranosyl-(1-6) -beta-D-glucopyranoside in the human intestinal cell line caco-2. Pharm Res (2006) 0.84
Modulation of function of multidrug resistance associated-proteins by Kaempferia parviflora extracts and their components. Eur J Pharmacol (2007) 0.83
Long-term effects of St. John's wort (Hypericum perforatum) treatment: a 1-year safety study in mild to moderate depression. Phytomedicine (2009) 0.82
The value of psychiatric treatment: its efficacy in severe mental disorders. Psychopharmacol Bull (1993) 0.81
Activation of rutin by human oral bacterial isolates to the carcinogen-mutagen quercetin. Arch Oral Biol (1983) 0.81
The beta-D-glucoside and sodium-dependent glucose transporter 1 (SGLT1)-inhibitor phloridzin is transported by both SGLT1 and multidrug resistance-associated proteins 1/2. Drug Metab Dispos (2003) 0.80
St. John's wort flavonoids and their metabolites show antidepressant activity and accumulate in brain after multiple oral doses. Pharmazie (2008) 0.80
Depression in adults with mild intellectual disability: role of stress, attributions, and coping. Am J Intellect Dev Disabil (2009) 0.80
Molecular mechanisms of the naringin low uptake by intestinal Caco-2 cells. Mol Nutr Food Res (2005) 0.79
A comparison of the relationship between depression, perceived disability, and physical performance in persons with chronic pain: a comment on Alschuler et al. (2008). Eur J Pain (2008) 0.77
Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature (2012) 18.23
EMAN2: an extensible image processing suite for electron microscopy. J Struct Biol (2006) 14.70
Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol (2008) 8.23
An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. Cancer Cell (2010) 6.76
Outcome of the first electron microscopy validation task force meeting. Structure (2012) 4.35
Sex differences in drug abuse. Front Neuroendocrinol (2007) 4.01
Hierarchical self-assembly of DNA into symmetric supramolecular polyhedra. Nature (2008) 3.92
Multistage nanoparticle delivery system for deep penetration into tumor tissue. Proc Natl Acad Sci U S A (2011) 3.34
Identification and characterization of a novel human histone H3 lysine 36-specific methyltransferase. J Biol Chem (2005) 2.68
Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis. Lancet Oncol (2013) 2.67
Common ancestry of herpesviruses and tailed DNA bacteriophages. J Virol (2005) 2.60
HPeak: an HMM-based algorithm for defining read-enriched regions in ChIP-Seq data. BMC Bioinformatics (2010) 2.41
Cryo-EM asymmetric reconstruction of bacteriophage P22 reveals organization of its DNA packaging and infecting machinery. Structure (2006) 2.26
Electron cryomicroscopy of biological machines at subnanometer resolution. Structure (2005) 2.15
Structural basis for scaffolding-mediated assembly and maturation of a dsDNA virus. Proc Natl Acad Sci U S A (2011) 2.03
Averaging tens to hundreds of icosahedral particle images to resolve protein secondary structure elements using a Multi-Path Simulated Annealing optimization algorithm. J Struct Biol (2007) 1.90
Disruption of PTEN coupling with 5-HT2C receptors suppresses behavioral responses induced by drugs of abuse. Nat Med (2006) 1.82
Absorption and metabolism of flavonoids in the caco-2 cell culture model and a perused rat intestinal model. Drug Metab Dispos (2002) 1.80
Noroviral P particle: structure, function and applications in virus-host interaction. Virology (2008) 1.75
The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia. Nat Med (2002) 1.75
A 9 angstroms single particle reconstruction from CCD captured images on a 200 kV electron cryomicroscope. J Struct Biol (2004) 1.70
Biodegradable quantum dot nanocomposites enable live cell labeling and imaging of cytoplasmic targets. Nano Lett (2008) 1.64
Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer. Genome Res (2011) 1.63
The mRNA expression of SATB1 and SATB2 in human breast cancer. Cancer Cell Int (2009) 1.62
Compact biocompatible quantum dots via RAFT-mediated synthesis of imidazole-based random copolymer ligand. J Am Chem Soc (2010) 1.60
Conformational flexibility facilitates self-assembly of complex DNA nanostructures. Proc Natl Acad Sci U S A (2008) 1.60
A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties. J Pharmacol Exp Ther (2004) 1.58
Metabolism of flavonoids via enteric recycling: role of intestinal disposition. J Pharmacol Exp Ther (2003) 1.55
Characterization of polymyxin B-induced nephrotoxicity: implications for dosing regimen design. Antimicrob Agents Chemother (2012) 1.52
Rotavirus architecture at subnanometer resolution. J Virol (2008) 1.48
Cooperation between Polycomb and androgen receptor during oncogenic transformation. Genome Res (2011) 1.47
Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21. Proc Natl Acad Sci U S A (2012) 1.46
Preparing for and responding to public health emergencies in China: a focus group study. J Public Health Policy (2007) 1.40
Norovirus P particle, a novel platform for vaccine development and antibody production. J Virol (2010) 1.39
Isolated sagittal and coronal craniosynostosis associated with TWIST box mutations. Am J Med Genet A (2007) 1.37
Enteric disposition and recycling of flavonoids and ginkgo flavonoids. J Altern Complement Med (2003) 1.37
Genome sequence, structural proteins, and capsid organization of the cyanophage Syn5: a "horned" bacteriophage of marine synechococcus. J Mol Biol (2007) 1.37
Identification of the position of mono-O-glucuronide of flavones and flavonols by analyzing shift in online UV spectrum (lambdamax) generated from an online diode array detector. J Agric Food Chem (2010) 1.33
Superparamagnetic iron oxide nanoparticles as MRI contrast agents for non-invasive stem cell labeling and tracking. Theranostics (2013) 1.33
Structure and concentration changes affect characterization of UGT isoform-specific metabolism of isoflavones. Mol Pharm (2009) 1.32
Zinc biofortification of cereals: rice differs from wheat and barley. Trends Plant Sci (2009) 1.30
Genome-wide survey and developmental expression mapping of zebrafish SET domain-containing genes. PLoS One (2008) 1.29
The first potent and selective non-imidazole human histamine H4 receptor antagonists. J Med Chem (2003) 1.28
Dual neuroprotective signaling mediated by downregulating two distinct phosphatase activities of PTEN. J Neurosci (2004) 1.28
Disposition of flavonoids via enteric recycling: structural effects and lack of correlations between in vitro and in situ metabolic properties. Drug Metab Dispos (2006) 1.28
Deriving folds of macromolecular complexes through electron cryomicroscopy and bioinformatics approaches. Curr Opin Struct Biol (2002) 1.27
First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics. J Pharm Sci (2011) 1.27
Pharmacokinetics and renal disposition of polymyxin B in an animal model. Antimicrob Agents Chemother (2012) 1.26
Cryo-EM structure of a novel calicivirus, Tulane virus. PLoS One (2013) 1.26
Absorption and metabolism of genistein and its five isoflavone analogs in the human intestinal Caco-2 model. Cancer Chemother Pharmacol (2004) 1.25
Terminal modifications of norovirus P domain resulted in a new type of subviral particles, the small P particles. Virology (2010) 1.25
Uridine diphosphate glucuronosyltransferase isoform-dependent regiospecificity of glucuronidation of flavonoids. J Agric Food Chem (2011) 1.24
Single particle cryo-electron microscopy and 3-D reconstruction of viruses. Methods Mol Biol (2014) 1.23
A validated ultra-performance liquid chromatography-tandem mass spectrometry method for the quantification of polymyxin B in mouse serum and epithelial lining fluid: application to pharmacokinetic studies. J Antimicrob Chemother (2013) 1.23
Coupling of conjugating enzymes and efflux transporters: impact on bioavailability and drug interactions. Curr Drug Metab (2005) 1.21
MicroRNA-217 promotes ethanol-induced fat accumulation in hepatocytes by down-regulating SIRT1. J Biol Chem (2012) 1.19
Clonal precursor of bone, cartilage, and hematopoietic niche stromal cells. Proc Natl Acad Sci U S A (2013) 1.19
Breast cancer resistance protein (ABCG2) determines distribution of genistein phase II metabolites: reevaluation of the roles of ABCG2 in the disposition of genistein. Drug Metab Dispos (2012) 1.19
Visualization of uncorrelated, tandem symmetry mismatches in the internal genome packaging apparatus of bacteriophage T7. Proc Natl Acad Sci U S A (2013) 1.19
Surface-plasmon-coupled emission of quantum dots. J Phys Chem B (2005) 1.17
'First-in-man': characterising the mechanosensitivity of human colonic afferents. Gut (2010) 1.17
Disposition of flavonoids via recycling: comparison of intestinal versus hepatic disposition. Drug Metab Dispos (2005) 1.16
Developmental phenotypes and reduced Wnt signaling in mice deficient for pygopus 2. Genesis (2007) 1.15
In vitro assessment and multicenter cohort study of comparative nephrotoxicity rates associated with colistimethate versus polymyxin B therapy. Antimicrob Agents Chemother (2014) 1.14
Commentary: bioavailability of flavonoids and polyphenols: call to arms. Mol Pharm (2007) 1.13
Diagnostic value of multislice computed tomography angiography in coronary artery disease: a meta-analysis. Eur J Radiol (2006) 1.13
Use of glucuronidation fingerprinting to describe and predict mono- and dihydroxyflavone metabolism by recombinant UGT isoforms and human intestinal and liver microsomes. Mol Pharm (2010) 1.13
Disposition of flavonoids via enteric recycling: enzyme-transporter coupling affects metabolism of biochanin A and formononetin and excretion of their phase II conjugates. J Pharmacol Exp Ther (2004) 1.13
Ovol1 regulates meiotic pachytene progression during spermatogenesis by repressing Id2 expression. Development (2005) 1.12
The mouse Ovol2 gene is required for cranial neural tube development. Dev Biol (2006) 1.11
Bioavailability challenges associated with development of anti-cancer phenolics. Mini Rev Med Chem (2010) 1.10
Validated near-atomic resolution structure of bacteriophage epsilon15 derived from cryo-EM and modeling. Proc Natl Acad Sci U S A (2013) 1.10
Nanoporous carbons through direct carbonization of a zeolitic imidazolate framework for supercapacitor electrodes. Chem Commun (Camb) (2012) 1.09
Disposition of flavonoids via enteric recycling: enzyme stability affects characterization of prunetin glucuronidation across species, organs, and UGT isoforms. Mol Pharm (2007) 1.09
Disposition of flavonoids via enteric recycling: determination of the UDP-glucuronosyltransferase isoforms responsible for the metabolism of flavonoids in intact Caco-2 TC7 cells using siRNA. Mol Pharm (2007) 1.09
Ab initio modeling of the herpesvirus VP26 core domain assessed by CryoEM density. PLoS Comput Biol (2006) 1.08
Molecular cloning and promoter analysis of downregulated in adenoma (DRA). Am J Physiol Gastrointest Liver Physiol (2007) 1.07
Temporal interplay between efflux pumps and target mutations in development of antibiotic resistance in Escherichia coli. Antimicrob Agents Chemother (2012) 1.06
Osteopontin expression profiles predict pathological and clinical outcome in breast cancer. Anticancer Res (2009) 1.05
Architecture of the herpes simplex virus major capsid protein derived from structural bioinformatics. J Mol Biol (2003) 1.05
In vitro potency of various polymyxin B components. Antimicrob Agents Chemother (2011) 1.05
Species- and disposition model-dependent metabolism of raloxifene in gut and liver: role of UGT1A10. Drug Metab Dispos (2005) 1.05
Lateral dimension-dependent antibacterial activity of graphene oxide sheets. Langmuir (2012) 1.05
The skeletal muscle Ca2+ release channel has an oxidoreductase-like domain. Proc Natl Acad Sci U S A (2002) 1.04
Biopharmaceutical and pharmacokinetic characterization of matrine as determined by a sensitive and robust UPLC-MS/MS method. J Pharm Biomed Anal (2009) 1.03
Validation of IMP dehydrogenase inhibitors in a mouse model of cryptosporidiosis. Antimicrob Agents Chemother (2013) 1.03
Natural polyphenol disposition via coupled metabolic pathways. Expert Opin Drug Metab Toxicol (2007) 1.03
Disposition of flavonoids via enteric recycling: UDP-glucuronosyltransferase (UGT) 1As deficiency in Gunn rats is compensated by increases in UGT2Bs activities. J Pharmacol Exp Ther (2009) 1.02
Localization of orexin-1 receptors to vagal afferent neurons in the rat and humans. Gastroenterology (2003) 1.02
Symmetry controls the face geometry of DNA polyhedra. J Am Chem Soc (2009) 1.02
Anisotropic intrinsic lattice thermal conductivity of phosphorene from first principles. Phys Chem Chem Phys (2015) 1.01
Potential beneficial metabolic interactions between tamoxifen and isoflavones via cytochrome P450-mediated pathways in female rat liver microsomes. Pharm Res (2004) 1.01
Enhancement of oral bioavailability of 20(S)-ginsenoside Rh2 through improved understanding of its absorption and efflux mechanisms. Drug Metab Dispos (2011) 1.01